Fluid delivery apparatus with an additive

• US 5,279,558 A
• Filed: 12/07/1992
• Issued: 01/18/1994
• Est. Priority Date: 06/16/1989
• Status: Expired due to Fees

• Current Assignee: Pescadero Beach Holdings Corporation
• Original Assignee: Science Incorporated
• Inventors: Kriesel, Marshall S.
• Primary Examiner(s): Rosenbaum, C. Fred
• Assistant Examiner(s): MCDERMOTT, CORRINE MARIE
• Application Number:
  US07/987,021
• Time in Patent Office: 407 Days
• Field of Search: 604/83-85, 604/122, 604/126, 604/131, 604/132, 604/149, 604/153, 604/212, 604/216, 604/217, 604/246, 604/247, 604/890.1, 128/DIG. 12
• US Class Current: 604/85
• CPC Class Codes: A61M 2205/197 by the seal material
• CPC Class Codes: A61M 5/1407 Infusion of two or more substances
• CPC Class Codes: A61M 5/1409 in series, e.g. first substance passing through container holding second substance, e.g. reconstitution systems needle sets A61M5/162
• CPC Class Codes: A61M 5/14248 of the skin patch type
• CPC Class Codes: A61M 5/152 pressurised by contraction of elastic reservoirs containers for dispensing contents by contraction of an elastic bag provided therein, in general B65D83/0061
• CPC Class Codes: Y10S 128/12 Pressure infusion

Abstract

An apparatus for accurately infusing medicinal agents into an ambulatory patient at specific rates over extended periods of time. The apparatus is of a compact, low profile, laminate construction and includes an elastic distendable membrane, which, in cooperation with a thin planar base, defines a fluid chamber having a fluid outlet. Disposed within the fluid chamber is a thin fluid permeable member which precisely controls the rate of fluid flow through the fluid outlet.

Claims

1. A device for use in infusing fluids into an ambulatory patient at a controlled rate comprising:

(a) a base having an upstanding portion including a fluid inlet passageway and a fluid outlet said fluid outlet and said fluid inlet passageways being interconnected by a fluid flow path;

(b) filling means for introducing fluid into said fluid inlet passageway, said filling means including filling check valve means for controlling the flow of fluid into said fluid inlet passageway;

(c) a distendable membrane constructed of an elastic material which is fitted over said base to define a chamber in communication with said fluid inlet and said fluid outlet, said membrane being distendable by fluid introduced into said chamber under pressure through said fluid inlet, said membrane having a tendency to return to a less distended configuration whereby fluid within said chamber will be expelled through said fluid outlet;

(d) adding means disposed within said fluid flow path for adding an additive to fluid flowing therethrough.

2. A device as defined in claim 1 in which said adding means comprises an additive and an additive presentation means for presenting said additive to the fluid, said additive presentation means being disposed within said fluid inlet passageway intermediate said fluid outlet and said filling check valve means.

3. A device as defined in claim 1 in which said adding means comprises an additive and an additive presentation means for presenting said additive to the fluid, said additive being removable from said additive presentation means using affinity chromotography techniques.

4. A device as defined in claim 3 in which said additive is removably connected to said additive presentation means using azlactone functional compounds.

5. A device as defined in claim 4 in which said adding means comprises a structural support disposed within a glass vial, said structural support having biologically active proteins bound thereto.

6. A device for use in infusing fluids into an ambulatory patient at a controlled rate comprising:

(a) a base having a fluid inlet, a fluid outlet passageway, and a fluid passageway interconnecting said fluid inlet and said fluid outlet passageway;

(b) filling means for introducing fluid into said fluid inlet;

(c) a distendable membrane constructed of an elastic material which is fitted over said base to define a chamber in communication with said fluid passageway, and with said membrane being distendable by fluid introduced into said chamber under pressure through said fluid inlet passageway and having a tendency to return to a less distended configuration whereby fluid within said chamber will be expelled through said fluid outlet; and

(d) adding means disposed within said fluid outlet passageway for adding an additive to fluid flowing therethrough, said adding means comprising a support and an additive removably connected to said support.

7. A device as defined in claim 6 in which said additive is substantially removable from said support using affinity chromotography techniques.

8. A device as defined in claim 7 in which a ligand is connected to said support and a target molecule is connected to said ligand.

9. A device as defined in claim 8 in which a spacer arm is connected to said support and in which a ligand is connected to said spacer arm.

10. A device as defined in claim 9 in which an enzyme is connected to said target molecule.

11. A device as defined in claim 9 in which said target molecule is a protein.

12. A device as defined in claim 11 in which an antibody is bound to said protein.

13. A device for use in infusing beneficial agents into a patient at a controlled rate comprising:

(a) a base having a fluid inlet, a fluid outlet passageway and a fluid passageway interconnecting said fluid inlet and said fluid outlet;

(b) filling means for introducing fluid into said fluid inlet;

(c) a distendable membrane constructed of an elastic material which is fitted over said base to define a chamber in communication with said fluid outlet passageway, said membrane distendable by fluid introduced into said chamber under pressure through said fluid passageway and having a tendency to return to a less distended configuration whereby fluid within said chamber will be expelled through said fluid outlet;

(d) adding means mounted within said fluid outlet passageway for adding an additive to fluid introduced by said filling means, said adding means comprising;

(i) additive presentation means disposed within said fluid passageway for presenting an additive to the fluid flowing therethrough; and

(ii) an additive substantially removably interconnected to said additive presentation means using affinity chromotography immobilization techniques.

14. A device as defined in claim 13 in which said filling means comprises a syringe assembly.

15. A device as defined in claim 13 in which said filling means comprises a needle assembly having a hollow needle connectable with a source of eluting fluid.

16. A device as defined in claim 13 in which said base includes an upstanding portion defining said fluid outlet passageway, said adhesive presentation means being receivable within said upstanding portion so that said additive will be exposed to fluid flowing through said fluid outlet passageway.

17. A device as defined in claim 16 in which said upstanding portion extends transversely of said base.

18. A device as defined in claim 16 in which said upstanding portion extends longitudinally of said base.

19. A device as defined in claim 16 in which said additive presentation means is contained within a glass vial receivable within said upstanding portion and in which said adding means further includes flow rate control means for controlling the rate of fluid flowing toward said additive presentation means.

20. A device as defined in claim 16 in which said additive presentation means is contained within a glass vial receivable within said upstanding portion and in which said adding means further includes flow rate control means for controlling the rate of fluid flowing away from said additive presentation means.

21. A device as defined in claim 13 in which said additive is removably connected to said additive presentation means using an immobilized ligand and a spacer arm means comprises a syringe assembly.

22. A device as defined in claim 13 in which said adding means comprises an additive which provides for extended release of a beneficial agent to the fluid over time.

23. A device as defined in claim 13 in which said additive presentation means provides for extended release of said additive over time.

24. A device for use in infusing beneficial agents into a patient at a controlled rate comprising:

(a) a base having a fluid inlet, a fluid outlet and a fluid passageway interconnecting said fluid inlet and said fluid outlet;

(b) filling means for introducing fluid into said fluid inlet;

(c) a distendable membrane constructed of an elastic material which is fitted over said base to define a chamber in communication with said fluid passageway, said membrane being distendable by fluid introduced into said chamber under pressure through said fluid passageway and having a tendency to return to a less distended configuration whereby fluid within said chamber will be expelled through said fluid outlet; and

(d) adding means for adding an additive to fluid introduced by said filling means, said adding means comprising;

(i) additive presentation means disposed within said fluid passageway for presenting an additive to the fluid flowing therethrough; and

(ii) an additive removably interconnected to said additive presentation means for removal using affinity chromotography techniques.

25. A device as defined in claim 24 in which said adding means comprises an additive which provides for extended release of a beneficial agent to the fluid over time.

26. A device as defined in claim 24 in which said additive presentation means provides for extended release of said additive over time.

27. A device as defined in claim 24 in which said additive presentation means comprises an immobilized ligand.

28. A device as defined in claim 27 in which a target molecule is affixed to said ligand.

29. A device as defined in claim 24 in which said additive presentation means comprises a spacer arm.

30. A device as defined in claim 29 in which a protein is connected to said spacer arm.

31. A device as defined in claim 30 in which an antibody is connected to said protein.

32. A device as defined in claim 30 in which a immunoglobulin is connected to said protein.

33. A device as defined in claim 30 in which an antibody is covalently attached to said protein, said antibody having binding sites facing outwardly from said protein.